Benzamide Based HDAC3 Selective Inhibitors
Inventors:
Prof. Balaram Ghosh , Prof. Swati Biswas, Prof. Routholla Ganesh, Prof. Pulya Sravani
This invention aims to provide chemical compounds and pharmaceutical compositions for selective inhibition of histone deacetylase (HDAC) enzymes
The invention provides compounds and pharmaceutical compositions, including those selectively inhibiting HDAC enzymes.
The invention introduces compounds and pharmaceutical compositions with specific structures targeting HDAC enzymes, potentially advancing treatments for various diseases and disorders.
Potential Indian Clients: Pharmaceutical companies involved in drug discovery and development, such as Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Lupin Limited, Cadila Healthcare Ltd., and Biocon Ltd.
Current TRL: NA
Funded by: NA
IPC: A61K, C07D
Domain: Pharmaceuticals/Drug Discovery
This website uses cookies or similar technologies, to enhance your browsing experience.